Business Context and Reporting Period
This Form 8-K Current Report was filed by iSpecimen Inc. (ISPC) on January 9, 2023. The filing addresses a significant change in executive leadership following the resignation of the previous CEO.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and personnel changes.
Material Changes
- CEO Appointment: The Board of Directors appointed Tracy Curley as Chief Executive Officer, effective immediately on January 9, 2023.
- Transition from Interim Role: Ms. Curley had previously served as Interim CEO since October 24, 2022, following the resignation of Christopher Ianelli.
- CFO Search: With Ms. Curley's promotion to CEO, the Board initiated a comprehensive search for a new Chief Financial Officer.
Management Commentary and Risks
Ms. Curley brings extensive experience in the technology and life sciences sectors, having served as CFO since August 2020 and as a partner at several national accounting firms (Cohn Reznick LLP, Marcum LLP, and Moody, Famiglietti & Andronico, LLP). The filing notes no family relationships between Ms. Curley and other directors or officers and discloses no related-party transactions requiring disclosure under Item 404(a) of Regulation S-K.
Investor Verification Checklist
- Confirm the official press release dated January 10, 2023, attached as Exhibit 99.1.
- Monitor future filings for the appointment of a permanent Chief Financial Officer.
- Review the company's most recent 10-K or 10-Q for financial performance data, as this 8-K contains no financial metrics.